tiprankstipranks
Trending News
More News >
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Income Statement

Compare
79 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q3 2025), XORTX Therapeutics Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, XORTX Therapeutics Inc's net income was C$-642.27K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -160.66K-C$ -75.27KC$ -17.88KC$ -20.44K
Operating Expenses
C$ 5.48MC$ 4.81MC$ 9.86MC$ 2.90MC$ 1.30M
Depreciation and Amortization
C$ 160.66KC$ 188.54KC$ 75.27KC$ 17.88KC$ 20.44K
EBITDA
C$ -4.38M-C$ -9.41M-C$ -1.25M
Operating Income
C$ -5.64M-C$ -12.43M-C$ -1.08M
Other Income/Expenses
C$ 1.10MC$ 1.95MC$ 2.95MC$ 1.25MC$ -202.36K
Pretax Income
C$ -4.54M-C$ -9.49MC$ -1.65MC$ -1.28M
Net Income
C$ -4.54M--C$ -1.65MC$ -1.28M
Per Share Metrics
Basic EPS
C$ -1.58C$ -1.44C$ -4.72C$ -1.20C$ -1.73
Diluted EPS
C$ -1.58C$ -1.44C$ -4.72C$ -1.20C$ -1.73
Weighted Average Shares Outstanding
2.88M 1.98M 1.48M 1.09M 740.45K
Weighted Average Shares Outstanding (Diluted)
2.88M 1.98M 1.48M 1.09M 740.45K
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History